Clinical and economic evidence thresholds for orphan drugs- Are requirements for favorable health technology assessment and reimbursement on the rise?

May 1, 2013, 00:00
10.1016/j.jval.2013.03.512
https://www.valueinhealthjournal.com/article/S1098-3015(13)00583-4/fulltext
Title : Clinical and economic evidence thresholds for orphan drugs- Are requirements for favorable health technology assessment and reimbursement on the rise?
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00583-4&doi=10.1016/j.jval.2013.03.512
First page : A108
Section Title : Neurological Disorders
Open access? : No
Section Order : 54
Categories :
Tags :
Regions :
ViH Article Tags :